Anne LAPRIE

https://tonic.inserm.fr/wp-content/uploads/2019/09/WIN_20200406_13_29_37_Pro-2-150x150.jpg

PU-PH

Travaille sur

Abstracts rédigés ou co-rédigés

> MR imaging predictor of survival in pediatric ependymoma patients after radiotherapy
F. Tensaouti, A. Ducassou, L. Chaltiel, A. Sevely, S. Bolle, X. Muracciole, B. Coche-Dequant, C. Alapetite, S. Supiot, A. Huchet,V. Bernier, L. Claude, A.I. Bertozzi-Salamon, P. Péran, P. Payoux, A. Laprie.
European SocieTy for Radiotherapy and Oncology (ESTRO) - VIENNE
> Patterns of failure after radiotherapy in pediatric ependymoma: correlation with dose parameters.
F.Tensaouti, A.Ducassou, S.Bolle, X.Muracciole, B.Coche-dequeant, L.Claude, S.Supiot, C.Alapetite, V.Bernier, A.Huchet, C.Kerr, E.Le Prise, G.Truc, E.Regnier, S.Chapet, A.Lisbona, G.Hangard, A.Laprie
ESTRO - European SocieTy of RADIOTHERAPY&ONCOLOGY - TURIN

Publications rédigées ou co-rédigées

> 19- Surface guided radiotherapy practice in paediatric oncology: a survey on behalf of the SIOPE radiation oncology working group.
Seravalli E, Kroon PS, Bolle S, Dunlea C, Harrabi SB, Laprie A, Lassen-Ramshad Y, Whitfield G, Janssens GO.
Br J Radiol. 2024 Mar 5:tqae049. doi: 10.1093/bjr/tqae049.
> 13- Brainstem toxicity after proton or photon therapy in children and young adults with localized intracranial ependymoma: a French retrospective study.
Dalmasso C, Alapetite C, Bolle S, Goudjil F, Lusque A, Desrousseaux J, Claude L, Doyen J, Bernier-Chastagner V, Ducassou A, Sevely A, Roques M, Tensaouti F, Laprie A.
adiother Oncol. 2024 Feb 15:110157. doi: 10.1016/j.radonc.2024.110157.
> 81- The long-term impact of irradiation on functional connectivity in brain circuits involved in memory processes after pediatric posterior fossa tumor.
Baudou E, Peran P, Tensaouti F, Arribarat G, Pariente J, Courbieres N, Pollidoro L, Bertozzi AI, Gambart M, Sevely A, Roques M, Ducassou A, Danna J, Tallet J, Dufour C, Chaix Y, Laprie A.
Radiother Oncol. 2023 Dec 23:110073. doi: 10.1016/j.radonc.2023.110073.
> 71- A Prospective Study of Arterial Spin Labelling in Paediatric Posterior Fossa Tumour Survivors: A Correlation with Neurocognitive Impairment.
Troudi A, Tensaouti F, Cabarrou B, Arribarat G, Pollidoro L, Péran P, Sevely A, Roques M, Chaix Y, Bertozzi AI, Gambart M, Ducassou A, Baudou E, Laprie A.
Clin Oncol (R Coll Radiol). 2023 Sep 29:S0936-6555(23)00339-4. doi: 10.1016/j.clon.2023.09.015.
> 55- RadioTransNet, Radiotherapy Translational and Preclinical Research Network: Results from the dedicated French cancer institute (INCa) call for projects.
Bayart É, De Crevoisier R, Laprie A, Milliat F, Prezado Y, Marchesi V, Maingon P.
Cancer Radiother. 2023 Jul 21:S1278-3218(23)00133-6. doi: 10.1016/j.canrad.2023.06.019.
> 51- Respective roles of surgery, chemotherapy and radiotherapy for recurrent pediatric and adolescent ependymoma: a national multicentric study.
Desrousseaux J, Claude L, Chaltiel L, Tensaouti F, Padovani L, Bolle S, Escande A, Alapetite C, Supiot S, Bernier-Chastagner V, Huchet A, Leseur J, Truc G, Leblond P, Bertozzi AI, Ducassou A, Laprie A.
Int J Radiat Oncol Biol Phys. 2023 Jul 10:S0360-3016(23)00367-X. doi: 10.1016/j.ijrobp.2023.04.008.
> 47- Randomized phase III trial of metabolic imaging-guided dose escalation of radio-chemotherapy in patients with newly diagnosed glioblastoma (SPECTRO GLIO trial).
Laprie A, Noel G, Chaltiel L, Truc G, Sunyach MP, Charissoux M, Magne N, Auberdiac P, Biau J, Ken S, Tensaouti F, Khalifa J, Sidibe I, Roux FE, Vieillevigne L, Catalaa I, Boetto S, Emmanuelle UC, Supiot S, Bernier V, Filleron T, Mounier M, Poublanc M, Olivier P, Delord JP, Cohen-Jonathan-Moyal E.
Neuro Oncol. 2023 Jul 7:noad119. doi: 10.1093/neuonc/noad119.
> 23- Impact of a pediatric posterior fossa tumor and its treatments on motor procedural learning.
Baudou E, Danna J, Tallet J, Pollidoro L, Tensaouti F, Bertozzi AI, Pariente J, Courbieres N, Dufour C, Grill J, Chaix Y, Laprie A.
Eur J Paediatr Neurol. 2023 Apr 10;44:37-45. doi: 10.1016/j.ejpn.2023.03.005.
> 18- Is pre-radiotherapy metabolic heterogeneity of glioblastoma predictive of progression-free survival?
Tensaouti F, Desmoulin F, Gilhodes J, Roques M, Ken S, Lotterie JA, Noël G, Truc G, Sunyach MP, Charissoux M, Magné N, Lubrano V, Péran P, Cohen-Jonathan Moyal E, Laprie A.
Radiother Oncol. 2023 Apr 4:109665. doi: 10.1016/j.radonc.2023.109665.
> 3- Pseudoprogression versus true progression in patients with glioblastoma: A multiapproach analysis.
Sidibe I, Tensaouti F, Gilhodes J, Cabarrou B, Filleron T, Desmoulin F, Ken S, Noël G, Truc G, Sunyach M, Charissoux M, Magné N, Lotterie JA, Roques M, Péran P, Cohen-Jonathan Moyal E, Laprie A.
Radiother Oncol. 2023 Jan 24:109486. doi: 10.1016/j.radonc.2023.109486.
> 66- Arterial Spin Labeling Perfusion in Pediatric Brain Tumors: A Review of Techniques, Quality Control, and Quantification.
Troudi A, Tensaouti F, Baudou E, Péran P, Laprie A.
Cancers (Basel). 2022 Sep 28;14(19):4734. doi: 10.3390/cancers14194734.
> 60- Radiation dose intensification for glioblastoma
Laprie A, Tensaouti F, Cohen-Jonathan Moyal E.
Cancer Radiother. 2022 Sep 6:S1278-3218(22)00159-7. doi: 10.1016/j.canrad.2022.07.007.
> 32- A review of long-term deficits in memory systems following radiotherapy for pediatric posterior fossa tumor.
Baudou E, Pollidoro L, Iannuzzi S, Bertozzi AI, Tensaouti F, Chaix Y, Laprie A.
Radiother Oncol. 2022 May 28:S0167-8140(22)02278-2. doi: 10.1016/j.radonc.2022.05.022.
> 11- Pseudoprogression in Glioblastoma: Role of Metabolic and Functional MRI-Systematic Review.
Sidibe I, Tensaouti F, Roques M, Cohen-Jonathan-Moyal E, Laprie A.
Biomedicines. 2022 Jan 26;10(2):285. doi: 10.3390/biomedicines10020285.
> 81- Quality control of 3D MRSI data in glioblastoma: Can we do without the experts?
Fatima Tensaouti, Franck Desmoulin, Julia Gilhodes, Elodie Martin, Soleakhena Ken, Jean-Albert Lotterie, Georges Noël, Gilles Truc, Marie-Pierre Sunyach, Marie Charissoux, Nicolas Magné, Vincent Lubrano, Patrice Péran, Elizabeth Cohen-Jonathan Moyal, Anne Laprie
Magn Reson Med. 2021 Nov 26.doi: 10.1002/mrm.29098.
> 72- A prospective behavioral and imaging study exploring the impact on long-term memory of radiotherapy delivered for a brain tumor in childhood and adolescence
Baudou E, Pariente P, Péran P, Tensaouti F, Pollidoro L, Meligne D, Ducassou A, Gros-Dagnac H, Arribarat G, Desirat JP, Bertozzi AI, Gambart M, Larrieu-Ciron D, Barbolosi D, Muracciole X, Lemesle B, Sevely A, Roques M, Laprie A
Clinical & Translational Radiation Oncology. 2021 oct. S2405-6308(21)00091-4 https://doi.org/10.1016/j.ctro.2021.10.006
> 37- Feasibility of Dose Escalation in Patients With Intracranial Pediatric Ependymoma
Tensaouti F, Ducassou A, Chaltiel L, Bolle S,Habrand JL, Alapetite C, Coche-Dequeant B, Bernier V, Claude L, Carrie C, Padovani L,Muracciole X, Supiot S, Huchet A, Leseur J, Kerr C, Hangard G, Lisbona A, Goudjil F, Ferrand R and Laprie A on behalf of the Radiotherapy Committee of the French Society for Childhood Cancer (SFCE), alias the French Paediatric Radiotherapy Group (GFRP)
Frontiers in Oncology, June 2019 Volume 9 Article 531doi: 10.3389/fonc.2019.00531
> 65- Recommendations for the organisation of care in paediatric radiation oncology across Europe: a SIOPE-ESTRO-PROS-CCI-Europe collaborative project in the framework of the JARC.
Janssens GO, Timmermann B, Laprie A, Mandeville H, Padovani L, Chargari C, Journy N, Kameric L, Kienesberger A, Brunhofer M, Kozhaeva O, Gasparotto C, Kearns P, Boterberg T, Lievens Y, Vassal G.
Eur J Cancer. 2019 Jun;114:47-54. doi: 10.1016/j.ejca.2019.03.003.
> 35- Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging.
Laprie A, Ken S, Filleron T, Lubrano V, Vieillevigne L, Tensaouti F, Catalaa I, Boetto S, Khalifa J, Attal J, Peyraga G, Gomez-Roca C, Uro-Coste E, Noel G, Truc G, Sunyach MP, Magné N, Charissoux M, Supiot S, Bernier V, Mounier M, Poublanc M, Fabre A, Delord JP, Cohen-Jonathan Moyal E.
BMC Cancer. 2019 Feb 21;19(1):167. doi: 10.1186/s12885-019-5317-x.
> 10- Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging.
Laprie A, Ken S, Filleron T, Lubrano V, Vieillevigne L, Tensaouti F, Catalaa I, Boetto S, Khalifa J, Attal J, Peyraga G, Gomez-Roca C, Uro-Coste E, Noel G, Truc G, Sunyach MP, Magné N, Charissoux M, Supiot S, Bernier V, Mounier M, Poublanc M, Fabre A, Delord JP, Cohen-Jonathan Moyal E.
BMC Cancer. 2019 Feb 21;19(1):167. doi: 10.1186/s12885-019-5317-x.
> 25- Pediatric localized intra cranial ependymomas: a multicenter analysis of the children’s cancer french society (SFCE) analysis of the children’s cancer french society (SFCE)
Ducassou A, Padovani L, Chaltiel L, Bolle S, Habrand JL, Claude L, Carrie C, Muracciole X, Coche-Dequeant B, Alapetite C, Supiot S, Demoor-Goldschmidt C, Bernier-Chastagner B, Huchet A, Leseur J, Le Prise E, Kerr C, Truc G, Nguyen T, Bertozzi A, Frappaz D, Boetto S, Sevely A, Tensaouti F, Laprie A
Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):166-173. doi: 10.1016/j.ijrobp.2018.05.036.
> 39- Pediatric Localized Intracranial Ependymomas: A Multicenter Analysis of the Société Française de lutte contre les Cancers de l’Enfant (SFCE) from 2000 to 2013.
Ducassou A, Padovani L, Chaltiel L, Bolle S, Habrand JL, Claude L, Carrie C, Muracciole X, Coche-Dequeant B, Alapetite C, Supiot S, Demoor-Goldschmidt C, Bernier-Chastagner V, Huchet A, Leseur J, Le Prise E, Kerr C, Truc G, Nguyen TD, Bertozzi AI, Frappaz D, Boetto S, Sevely A, Tensaouti F, Laprie A;
Pediatric French Radiation Oncologist Group (GFRP) and the French Society of Children With Cancer (SFCE). Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):166-173. doi: 10.1016/j.ijrobp.2018.05.036. Epub 2018 May 24.
> 51- Imaging biomarkers of outcome after radiotherapy for pediatric ependymoma.
Tensaouti F, Ducassou A, Chaltiel L, Sevely A, Bolle S, Padovani L, Jouin A, Alapetite C, Supiot S, Huchet A, Bernier V, Claude L, Kerr C, Le Prisé E, Bertozzi-Salamon AI, Liceaga S, Lotterie JA, Péran P, Laprie A; French Society for Childhood Cancer (SFCE).
Radiother Oncol. 2018 Apr;127(1):103-107. doi: 10.1016/j.radonc.2018.02.008.
> 8- Imaging biomarkers of outcome after radiotherapy for pediatric ependymoma.
Tensaouti F, Ducassou A, Chaltiel L, Sevely A, Bolle S, Padovani L, Jouin A, Alapetite C, Supiot S, Huchet A, Bernier V, Claude L, Kerr C, Le Prisé E, Bertozzi-Salamon AI, Liceaga S, Lotterie JA, Péran P, Laprie A;
French Society for Childhood Cancer (SFCE). Radiother Oncol. 2018 Feb 27. pii: S0167-8140(18)30064-1. doi: 10.1016/j.radonc.2018.02.008.
> 44- Response Assessment in Neuro-Oncology criteria, contrast enhancement and perfusion MRI for assessing progression in glioblastoma.
Tensaouti F, Khalifa J, Lusque A, Plas B, Lotterie JA, Berry I, Laprie A, Cohen-Jonathan Moyal E, Lubrano V.
Neuroradiology. 2017 Oct;59(10):1013-1020. doi: 10.1007/s00234-017-1899-7.
> 6- Patterns of failure after radiotherapy for pediatric patients with intracranial ependymoma
Fatima Tensaouti, Anne Ducassou, Léonor Chaltiel, Stéphanie Bolle, Xavier Muracciole, Bernard Coche-Dequeant, Claire Alapetite, Valérie Bernier, Line Claude, Stéphane Supiot, Aymeri Huchet, Christine Kerr, Elisabeth le Prisé, Anne Laprie
Anne Laprie RadiotherOncol (2017),http://dx.doi.org/10.1016/j.radonc.2016.12.025
> 52- Patterns of failure after radiotherapy for pediatric patients with intracranial ependymoma.
Tensaouti F, Ducassou A, Chaltiel L, Bolle S, Muracciole X, Coche-Dequeant B, Alapetite C, Bernier V, Claude L, Supiot S, Huchet A, Kerr C, le Prisé E, Laprie A; radiotherapy committee of the French Society for Childhood Cancer (SFCE).
Radiother Oncol. 2017 Mar;122(3):362-367. doi: 10.1016/j.radonc.2016.12.025. Epub 2017 Jan 12.
> 41- Identification of a candidate biomarker from perfusion MRI to anticipate glioblastoma progression after chemoradiation.
Khalifa J, Tensaouti F, Chaltiel L, Lotterie JA, Catalaa I, Sunyach MP, Ibarrola D, Noël G, Truc G, Walker P, Magné N, Charissoux M, Ken S, Peran P, Berry I, Moyal EC, Laprie A.
Eur Radiol. 2016 Nov;26(11):4194-4203.
> 53- Prognostic and predictive values of diffusion and perfusion MRI in paediatric intracranial ependymomas in a large national study.
Tensaouti F, Ducassou A, Chaltiel L, Sevely A, Bolle S, Muracciole X, Coche-Dequant B, Alapetite C, Supiot S, Huchet A, Bernier V, Claude L, Bertozzi-Salamon AI, Liceaga S, Lotterie JA, Péran P, Payoux P, Laprie A; radiotherapy committee of the French Society for Childhood Cancer (SFCE)..
Br J Radiol. 2016 Oct;89(1066):20160537. doi: 10.1259/bjr.20160537.
> 59- Do perfusion and diffusion MRI predict glioblastoma relapse sites following chemoradiation?
Khalifa J, Tensaouti F, Lotterie JA, Catalaa I, Chaltiel L, Benouaich-Amiel A, Gomez-Roca C, Noël G, Truc G, Péran P, Berry I, Sunyach MP, Charissoux M, Johnson C, Cohen-Jonathan Moyal E, Laprie A.
J Neurooncol. 2016 Oct;130(1):181-192.
> 48- Spatio-spectral regularization to improve magnetic resonance spectroscopic imaging quantification.
Laruelo A, Chaari L, Tourneret JY, Batatia H, Ken S, Rowland B, Ferrand R, Laprie A.
NMR Biomed. 2016 Jul;29(7):918-31. doi: 10.1002/nbm.3532.
> Dosimetric comparison between helical tomotherapy and volumetric modulated arc-therapy for non-anaplastic thyroid cancer treatment.
Khalifa J, Vieillevigne L, Boyrie S, Ouali M, Filleron T, Rives M, Laprie A.
Radiat Oncol. 2014 Nov 26;9:247. doi: 10.1186/s13014-014-0247-x.
> [Which dose constraints on which critical organs in paediatric radiation therapy?].
Claude L, Laprie A.
Cancer Radiother. 2015 Oct;19(6-7):484-8. doi: 10.1016/j.canrad.2015.07.016. French.
> Voxel-based evidence of perfusion normalization in glioblastoma patients included in a phase I-II trial of radiotherapy/tipifarnib combination.
Ken S, Deviers A, Filleron T, Catalaa I, Lotterie JA, Khalifa J, Lubrano V, Berry I, Péran P, Celsis P, Moyal EC, Laprie A.
J Neurooncol. 2015 Sep;124(3):465-73. doi: 10.1007/s11060-015-1860-8.
> Dosimetric comparison between helical tomotherapy and volumetric modulated arc-therapy for non-anaplastic thyroid cancer treatment.
Khalifa J, Vieillevigne L, Boyrie S, Ouali M, Filleron T, Rives M, Laprie A.
Radiat Oncol. 2014 Nov 26;9:247. doi: 10.1186/s13014-014-0247-x.